148 related articles for article (PubMed ID: 10897033)
1. Transformation of BALB3T3 cells caused by over-expression of rat CD98 heavy chain (HC) requires its association with light chain: mis-sense mutation in a cysteine residue of CD98HC eliminates its transforming activity.
Shishido T; Uno S; Kamohara M; Tsuneoka-Suzuki T; Hashimoto Y; Enomoto T; Masuko T
Int J Cancer; 2000 Aug; 87(3):311-6. PubMed ID: 10897033
[TBL] [Abstract][Full Text] [Related]
2. Enhanced tumorigenicity caused by truncation of the extracellular domain of GP125/CD98 heavy chain.
Hara K; Kudoh H; Enomoto T; Hashimoto Y; Masuko T
Oncogene; 2000 Dec; 19(54):6209-15. PubMed ID: 11175335
[TBL] [Abstract][Full Text] [Related]
3. Malignant transformation of NIH3T3 cells by overexpression of early lymphocyte activation antigen CD98.
Hara K; Kudoh H; Enomoto T; Hashimoto Y; Masuko T
Biochem Biophys Res Commun; 1999 Sep; 262(3):720-5. PubMed ID: 10471392
[TBL] [Abstract][Full Text] [Related]
4. Distinct domains of CD98hc regulate integrins and amino acid transport.
Fenczik CA; Zent R; Dellos M; Calderwood DA; Satriano J; Kelly C; Ginsberg MH
J Biol Chem; 2001 Mar; 276(12):8746-52. PubMed ID: 11121428
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk between RANKL and FRP-1/CD98 Systems: RANKL-mediated osteoclastogenesis is suppressed by an inhibitory anti-CD98 heavy chain mAb and CD98-mediated osteoclastogenesis is suppressed by osteoclastogenesis inhibitory factor.
Mori K; Miyamoto N; Higuchi Y; Nanba K; Ito M; Tsurudome M; Nishio M; Kawano M; Uchida A; Ito Y
Cell Immunol; 2001 Feb; 207(2):118-26. PubMed ID: 11243701
[TBL] [Abstract][Full Text] [Related]
6. Identification and immunological characterization of a novel 40-kDa protein linked to CD98 antigen.
Matsumoto Y; Satoh-Ueno K; Yoshimura A; Hashimoto Y; Enomoto T; Masuko T
Cell Struct Funct; 1999 Aug; 24(4):217-26. PubMed ID: 10532356
[TBL] [Abstract][Full Text] [Related]
7. Monocyte-dependent regulation of T lymphocyte activation through CD98.
Diaz LA; Friedman AW; He X; Kuick RD; Hanash SM; Fox DA
Int Immunol; 1997 Sep; 9(9):1221-31. PubMed ID: 9310825
[TBL] [Abstract][Full Text] [Related]
8. Cutting edge: primary structure of the light chain of fusion regulatory protein-1/CD98/4F2 predicts a protein with multiple transmembrane domains that is almost identical to the amino acid transporter E16.
Tsurudome M; Ito M; Takebayashi S; Okumura K; Nishio M; Kawano M; Kusagawa S; Komada H; Ito Y
J Immunol; 1999 Mar; 162(5):2462-6. PubMed ID: 10072483
[TBL] [Abstract][Full Text] [Related]
9. Identification of the transformation-associated cell surface antigen expressed on the rat fetus-derived fibroblast.
Yagihashi A; Sato N; Torigoe T; Okubo M; Konno A; Takahashi N; Yamashita T; Fujinaga K; Kuzumaki N; Kikuchi K
Cancer Res; 1988 May; 48(10):2798-804. PubMed ID: 3162824
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of LAT1/CD98 light chain is sufficient to increase system L-amino acid transport activity in mouse hepatocytes but not fibroblasts.
Campbell WA; Thompson NL
J Biol Chem; 2001 May; 276(20):16877-84. PubMed ID: 11278397
[TBL] [Abstract][Full Text] [Related]
11. The amino acid transport system y+L/4F2hc is a heteromultimeric complex.
Estévez R; Camps M; Rojas AM; Testar X; Devés R; Hediger MA; Zorzano A; Palacín M
FASEB J; 1998 Oct; 12(13):1319-29. PubMed ID: 9761775
[TBL] [Abstract][Full Text] [Related]
12. Suppression of the tumorigenicity of mutant p53-transformed rat embryo fibroblasts through expression of a newly cloned rat nonmuscle myosin heavy chain-B.
Yam JW; Chan KW; Hsiao WL
Oncogene; 2001 Jan; 20(1):58-68. PubMed ID: 11244504
[TBL] [Abstract][Full Text] [Related]
13. Tumor rejection antigens on BALB3T3 cells transformed by activated oncogenes.
Torigoe T; Sato N; Takashima T; Cho JM; Tsuboi N; Qi WM; Hara I; Wada Y; Takahashi N; Kikuchi K
J Immunol; 1991 Nov; 147(9):3251-8. PubMed ID: 1919013
[TBL] [Abstract][Full Text] [Related]
14. TA1/LAT-1/CD98 light chain and system L activity, but not 4F2/CD98 heavy chain, respond to arginine availability in rat hepatic cells. Loss Of response in tumor cells.
Campbell WA; Sah DE; Medina MM; Albina JE; Coleman WB; Thompson NL
J Biol Chem; 2000 Feb; 275(8):5347-54. PubMed ID: 10681508
[TBL] [Abstract][Full Text] [Related]
15. CD98hc (SLC3A2) interaction with beta 1 integrins is required for transformation.
Henderson NC; Collis EA; Mackinnon AC; Simpson KJ; Haslett C; Zent R; Ginsberg M; Sethi T
J Biol Chem; 2004 Dec; 279(52):54731-41. PubMed ID: 15485886
[TBL] [Abstract][Full Text] [Related]
16. Conditional deletion of CD98hc inhibits osteoclast development.
Tsumura H; Ito M; Takami M; Arai M; Li XK; Hamatani T; Igarashi A; Takada S; Miyado K; Umezawa A; Ito Y
Biochem Biophys Rep; 2016 Mar; 5():203-210. PubMed ID: 28955825
[TBL] [Abstract][Full Text] [Related]
17. Reduced invasive and metastatic potentials of KAI1-transfected melanoma cells.
Takaoka A; Hinoda Y; Sato S; Itoh F; Adachi M; Hareyama M; Imai K
Jpn J Cancer Res; 1998 Apr; 89(4):397-404. PubMed ID: 9617345
[TBL] [Abstract][Full Text] [Related]
18. Deletion of CD98 heavy chain in T cells results in cardiac allograft acceptance by increasing regulatory T cells.
Liu Z; Hou J; Chen J; Tsumura H; Ito M; Ito Y; Hu X; Li XK
Transplantation; 2012 Jun; 93(11):1116-24. PubMed ID: 22588539
[TBL] [Abstract][Full Text] [Related]
19. Endogenous fibroblast growth factor-1 or fibroblast growth factor-2 modulate prostate cancer cell proliferation.
Shain SA; Sarić T; Ke LD; Nannen D; Yoas S
Cell Growth Differ; 1996 May; 7(5):573-86. PubMed ID: 8732667
[TBL] [Abstract][Full Text] [Related]
20. Tumorigenicity of BALB3T3 A31 cells transfected with hamster-complement-C1s cDNA.
Sakai N; Kusunoki M; Nishida M; Toyoguchi T; Fukutomi H; Sakiyama H
Int J Cancer; 1994 Jul; 58(2):309-13. PubMed ID: 8026891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
